News
Important Only
Gri Bio Announces Additional Positive Data From Phase 2A Study In Idiopathic Pulmonary Fibrosis
Jan 8 (Reuters) - GRI Bio Inc GRI.O:GRI BIO ANNOUNCES ADDITIONAL POSITIVE DATA FROM PHASE 2A STUDY IN IDIOPATHIC PULMONARY FIBROSIS, STRENGTHENING CLINICAL PROOF-OF-CONCEPT FOR GRI-0621GRI BIO INC: GRI-0621 CONTINUES TO DEMONSTRATE A COMPELLING PROFILE, COMBINING FAVORABLE SAFETY AND TOLERABILITYReuters
Thu, Jan 8
BMW to launch 10 new cars in India and hike local sourcing to expand luxury sales
BMW to launch 10 new models, 17 upgrades in India in 2026EVs make up 21% of BMW's 2025 India sales vs 8% in 2024Set to source more parts locally to cut costs, boost salesCEO Brar urges long-term tax support for growthBy Aditi ShahMUMBAI, Jan 8 (Reuters) - BMW BMWG.DE will launch 10 new cars in I...Reuters
Thu, Jan 8
Cizzle Brands Adds Vertical Integration With $83.75M Acquisition Of Flow Water Inc
Jan 8 (Reuters) - Cizzle Brands Corp CZZL.NLB:CIZZLE BRANDS ADDS VERTICAL INTEGRATION WITH $83.75M ACQUISITION OF FLOW WATER INC.; SECURES MINIMUM VOLUME COMMITMENTS WORTH $184M IN MANUFACTURING CONTRACTSReuters
Thu, Jan 8
New York's Cooper Union settles campus antisemitism case, pledges reforms
School to hire Title VI coordinatorJewish students were locked in library during rallyMany schools were sued over alleged antisemitismCooper Union not immediately available for commentBy Jonathan Stempel NEW YORK, Jan 8 (Reuters) - Cooper Union for the Advancement of Science and Art will take ste...Reuters
Thu, Jan 8
RPT-BREAKINGVIEWS-Warner Bros defenses keep getting flimsier
By Jennifer SabaNEW YORK, Jan 7 (Reuters Breakingviews) - Warner Bros Discovery’s WBD.O excuses are getting thin. The entertainment empire's board rejected a revised $108 billion takeover entreaty from Paramount PSKY.O and stuck with its agreed partial sale to Netflix NFLX.O. After getting prac...Reuters
Thu, Jan 8
RPT-BREAKINGVIEWS-Software deal models AI buyout options
By Pranav Kiran TORONTO, Jan 7 (Reuters Breakingviews) - Private equity can afford to buy some options on artificial intelligence-driven disruption. European investor Hg Capital on Tuesday agreed to take software company OneStream private in a $6.4 billion deal. Just based on current expectation...Reuters
Thu, Jan 8
RPT-BREAKINGVIEWS-Grok deepfakes expose limits of investor morality
By Jeffrey GoldfarbNEW YORK, Jan 7 (Reuters Breakingviews) - The investing pendulum has now swung fully from championing social causes to decidedly antisocial behavior. Elon Musk's xAI just raised another $20 billion even as a worldwide backlash against sexualized deepfakes served up by the vent...Reuters
Thu, Jan 8
Murphy Oil Corporation Announces Offering Of $500 Million Of Senior Notes Due 2034
Jan 8 (Reuters) - Murphy Oil Corp MUR.N:MURPHY OIL CORPORATION ANNOUNCES OFFERING OF $500 MILLION OF SENIOR NOTES DUE 2034MURPHY OIL CORP - PROCEEDS TO FUND REDEMPTION OF IN FULL OF ITS 5.875% NOTES DUE 2027 AND ITS 6.375% NOTES DUE 2028MURPHY OIL CORP - ALSO, PROCEEDS TO REPAY OUTSTANDING BORROWING...Reuters
Thu, Jan 8
Trevi Therapeutics Provides Strategic Updates Ahead Of Annual Lifesci Partners Corporate Access Event
Jan 8 (Reuters) - Trevi Therapeutics Inc TRVI.O:TREVI THERAPEUTICS PROVIDES STRATEGIC UPDATES AHEAD OF ANNUAL LIFESCI PARTNERS CORPORATE ACCESS EVENT HELD DURING THE J.P. MORGAN HEALTHCARE CONFERENCETREVI THERAPEUTICS INC - FDA END-OF-PHASE 2 MEETING SCHEDULED FOR Q1 2026TREVI THERAPEUTICS INC - PHA...Reuters
Thu, Jan 8
Plus Therapeutics Announces Read Out Of Type B Meeting With The FDA
Jan 8 (Reuters) - Plus Therapeutics Inc PSTV.O:PLUS THERAPEUTICS ANNOUNCES READ OUT OF TYPE B MEETING WITH THE FDA WITH GOAL OF ACCELERATING APPROVAL OF REYOBIQ™ FOR LEPTOMENINGEAL METASTASESPLUS THERAPEUTICS INC - FDA INDICATES ACCELERATED APPROVAL MAY BE APPROPRIATE FOR LMPLUS THERAPEUTICS INC - F...Reuters
Thu, Jan 8
Kahr Bio Announces Strong Topline Phase 2 Results For Dsp107
Jan 8 (Reuters) - KAHR BIO ANNOUNCES STRONG TOPLINE PHASE 2 RESULTS FOR DSP107 IN COMBINATION WITH ANTI-PD-L1 THERAPY IN COLORECTAL CANCERKAHR BIO: PHASE 2 DATA DEMONSTRATED 17.5-MONTH MEDIAN OVERALL SURVIVALKAHR BIO: INTERIM RESULTS ANTICIPATED IN LATE 2026; TOPLINE DATA EXPECTED IN H2/2027Further ...Reuters
Thu, Jan 8
Cyera Raises $400M To Meet Rapidly Growing Demand For Ai Security Among Enterprises
Jan 8 (Reuters) - Blackstone Inc BX.N:CYERA RAISES $400M TO MEET RAPIDLY GROWING DEMAND FOR AI SECURITY AMONG ENTERPRISESCYERA: ROUND LED BY FUNDS MANAGED BY BLACKSTONE WITH INVESTORS INCLUDING ACCEL, COATUE, LIGHTSPEED VENTURE PARTNERS, , SAPPHIRE, OTHERSCYERA - $400 MILLION SERIES F FUNDING ROUND,...Reuters
Thu, Jan 8
Agf Investments Launches ETF Series For Legacy Funds Agf American Growth Fund And Agf Global Select Fund
Jan 8 (Reuters) - AGF Management Ltd AGFb.TO:AGF INVESTMENTS LAUNCHES ETF SERIES FOR LEGACY FUNDS: AGF AMERICAN GROWTH FUND AND AGF GLOBAL SELECT FUNDFurther company coverage: [AGFb.TO]Reuters
Thu, Jan 8
Acrivon Therapeutics Announces Positive Acr-368 Phase 2B Endometrial Cancer Clinical Data
Jan 8 (Reuters) - Acrivon Therapeutics Inc ACRV.O:ACRIVON THERAPEUTICS ANNOUNCES POSITIVE ACR-368 PHASE 2B ENDOMETRIAL CANCER CLINICAL DATA WITH EU EXPANSION TO ACCELERATE ENROLLMENT, INITIAL ACR-2316 CLINICAL DATA, AND ACR-6840, ITS NEXT AP3-ENABLED DEVELOPMENT CANDIDATE, TARGETING CDK11ACRIVON THE...Reuters
Thu, Jan 8
Alveus Therapeutics Raises $160 Million in Series A Financing
Jan 8 (Reuters) - ALVEUS THERAPEUTICS LAUNCHES WITH $160 MILLION SERIES A FINANCING TO ADVANCE NEXT-GENERATION THERAPIES FOR OBESITY AND METABOLIC DISEASESALVEUS: FINANCING SUPPORTS PHASE 2 DEVELOPMENT OF ALV-100, IND FILING OF ALV-200 AND ADVANCEMENT OF ADDITIONAL PROGRAMS ACROSS RESEARCH AND DEVEL...Reuters
Thu, Jan 8
